Pathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14

Infection and Immunity

Volumn 78, Issue 4, 2010, Pages 1437-1446

  Harrison, Ewan M ^a   Carter, Melissa E K ^a   Luck, Shelley ^c   Ou, Hong Yu ^d   He, Xinyi ^d   Deng, Zixin ^d   O'Callaghan, Chris ^a   Kadioglu, Aras ^a   Rajakumar, Kumar ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DISEASE MODEL; MOUSE; NONHUMAN; PAPI 1; PAPI 2; PATHOGENICITY ISLAND; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; WILD TYPE;

ANIMALS; BACTEREMIA; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENOMIC ISLANDS; MICE; MICE, INBRED BALB C; MULTIGENE FAMILY; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE DELETION; VIRULENCE FACTORS;

EID: 77950217695     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00621-09     Document Type: Article

References (65)

1. Allewelt, M., F. T. Coleman, M. Grout, G. P. Priebe, and G. B. Pier. 2000. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect. Immun. 68:3998-4004.
2. Antonopoulou, A., M. Raftogiannis, E. J. Giamarellos-Bourboulis, P. Koutoukas, L. Sabracos, M. Mouktaroudi, T. Adamis, I. Tzepi, H. Giamarellou, and E. E. Douzinas. 2007. Early apoptosis of blood monocytes is a determinant of survival in experimental sepsis by multi-drug-resistant Pseudomonas aeruginosa. Clin. Exp. Immunol. 149:103-108.
3. Ashkar, A. A., K. L. Mossman, B. K. Coombes, C. L. Gyles, and R. Mackenzie. 2008. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog. 4:e1000233.
4. Augustin, D. K., Y. Song, M. S. Baek, Y. Sawa, G. Singh, B. Taylor, A. Rubio-Mills, J. L. Flanagan, J. P. Wiener-Kronish, and S. V. Lynch. 2007. Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa. J. Bacteriol. 189:2203-2209.
5. Battle, S. E., F. Meyer, J. Rello, V. L. Kung, and A. R. Hauser. 2008. Hybrid pathogenicity island PAGI-5 contributes to the highly virulent phenotype of a Pseudomonas aeruginosa isolate in mammals. J. Bacteriol. 190:7130-7140.
6. Battle, S. E., J. Rello, and A. R. Hauser. 2009. Genomic islands of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 290:70-78.
7. Brzuszkiewicz, E., H. Bruggemann, H. Liesegang, M. Emmerth, T. Olschlager, G. Nagy, K. Albermann, C. Wagner, C. Buchrieser, L. Emody, G. Gottschalk, J. Hacker, and U. Dobrindt. 2006. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl. Acad. Sci. U. S. A. 103:12879-12884.
8. Choi, J. Y., C. D. Sifri, B. C. Goumnerov, L. G. Rahme, F. M. Ausubel, and S. B. Calderwood. 2002. Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis. J. Bacteriol. 184:952-961.
9. Choi, K. H., and H. P. Schweizer. 2005. An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol. 5:30.
10. Diaz, M. H., C. M. Shaver, J. D. King, S. Musunuri, J. A. Kazzaz, and A. R. Hauser. 2008. Pseudomonas aeruginosa induces localized immuno-suppression during pneumonia. Infect. Immun. 76:4414-4421.
11. Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743.
12. El Solh, A. A., M. E. Akinnusi, J. P. Wiener-Kronish, S. V. Lynch, L. A. Pineda, and K. Szarpa. 2008. Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 178:513-519.
13. Evans, D. J., D. W. Frank, V. Finck-Barbancon, C. Wu, and S. M. Fleiszig. 1998. Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity. Infect. Immun. 66:1453-1459.
14. Gerlach, R. G., N. Claudio, M. Rohde, D. Jackel, C. Wagner, and M. Hensel. 2008. Cooperation of Salmonella pathogenicity islands 1 and 4 is required to breach epithelial barriers. Cell. Microbiol. 10:2364-2376.
15. Gerlach, R. G., D. Jackel, N. Geymeier, and M. Hensel. 2007. Salmonella pathogenicity island 4-mediated adhesion is coregulated with invasion genes in Salmonella enterica. Infect. Immun. 75:4697-4709.
16. Giamarellos-Bourboulis, E. J., C. Routsi, D. Plachouras, V. Markaki, M. Raftogiannis, D. Zervakis, V. Koussoulas, S. Orfanos, A. Kotanidou, A. Armaganidis, C. Roussos, and H. Giamarellou. 2006. Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? Crit. Care 10:R76.
17. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
18. Hauser, A. R., E. Cobb, M. Bodi, D. Mariscal, J. Valles, J. N. Engel, and J. Rello. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30:521-528.
19. He, J., R. L. Baldini, E. Deziel, M. Saucier, Q. Zhang, N. T. Liberati, D. Lee, J. Urbach, H. M. Goodman, and L. G. Rahme. 2004. The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc. Natl. Acad. Sci. U. S. A. 101:2530-2535.
20. Hendrickson, E. L., J. Plotnikova, S. Mahajan-Miklos, L. G. Rahme, and F. M. Ausubel. 2001. Differential roles of the Pseudomonas aeruginosa PA14 rpoN gene in pathogenicity in plants, nematodes, insects, and mice. J. Bacteriol. 183:7126-7134.
21. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.
22. Inglis, R. F., A. Gardner, P. Cornelis, and A. Buckling. 2009. Spite and virulence in the bacterium Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 106:5703-5707.
23. Juhas, M., D. W. Crook, I. D. Dimopoulou, G. Lunter, R. M. Harding, D. J. Ferguson, and D. W. Hood. 2007. Novel type IV secretion system involved in propagation of genomic islands. J. Bacteriol. 189:761-771.
24. Kadioglu, A., N. A. Gingles, K. Grattan, A. Kerr, T. J. Mitchell, and P. W. Andrew. 2000. Host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 68:492-501.
25. Kintz, E., and J. B. Goldberg. 2008. Regulation of lipopolysaccharide O antigen expression in Pseudomonas aeruginosa. Future Microbiol. 3:191-203.
26. Klockgether, J., O. Reva, K. Larbig, and B. Tummler. 2004. Sequence analysis of the mobile genome island pKLC102 of Pseudomonas aeruginosa C. J. Bacteriol. 186:518-534.
27. Klockgether, J., D. Wurdemann, O. Reva, L. Wiehlmann, and B. Tummler. 2007. Diversity of the abundant pKLC102/PAGI-2 family of genomic islands in Pseudomonas aeruginosa. J. Bacteriol. 189:2443-2459.
28. Knodler, L. A., and B. B. Finlay. 2001. Salmonella and apoptosis: to live or let die? Microbes Infect. 3:1321-1326.
29. Kukavica-Ibrulj, I., A. Bragonzi, M. Paroni, C. Winstanley, F. Sanschagrin, G. A. O'Toole, and R. C. Levesque. 2008. In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J. Bacteriol. 190:2804-2813.
30. Kulasekara, B. R., H. D. Kulasekara, M. C. Wolfgang, L. Stevens, D. W. Frank, and S. Lory. 2006. Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa. J. Bacteriol. 188:4037-4050.
31. Lee, D. G., J. M. Urbach, G. Wu, N. T. Liberati, R. L. Feinbaum, S. Miyata, L. T. Diggins, J. He, M. Saucier, E. Deziel, L. Friedman, L. Li, G. Grills, K. Montgomery, R. Kucherlapati, L. G. Rahme, and F. M. Ausubel. 2006. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol. 7:R90.
32. Lee, V. T., R. S. Smith, B. Tummler, and S. Lory. 2005. Activities of Pseudomonas aeruginosa effectors secreted by the type III secretion system in vitro and during infection. Infect. Immun. 73:1695-1705.
33. Lin, D., C. V. Rao, and J. M. Slauch. 2008. The Salmonella SPI1 type three secretion system responds to periplasmic disulfide bond status via the flagellar apparatus and the RcsCDB system. J. Bacteriol. 190:87-97.
34. Luck, S. N., L. Badea, V. Bennett-Wood, R. Robins-Browne, and E. L. Hartland. 2006. Contribution of FliC to epithelial cell invasion by enterohemorrhagic Escherichia coli O113:H21. Infect. Immun. 74:6999-7004.
35. Marriott, H. M., P. G. Hellewell, S. S. Cross, P. G. Ince, M. K. Whyte, and D. H. Dockrell. 2006. Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia. J. Immunol. 177:6480-6488.
36. Mathee, K., G. Narasimhan, C. Valdes, X. Qiu, J. M. Matewish, M. Koehrsen, A. Rokas, C. N. Yandava, R. Engels, E. Zeng, R. Olavarietta, M. Doud, R. S. Smith, P. Montgomery, J. R. White, P. A. Godfrey, C. Kodira, B. Birren, J. E. Galagan, and S. Lory. 2008. Dynamics of Pseudomonas aeruginosa genome evolution. Proc. Natl. Acad. Sci. U. S. A. 105:3100-3105.
37. McMorran, B., L. Town, E. Costelloe, J. Palmer, J. Engel, D. Hume, and B. Wainwright. 2003. Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection. Infect. Immun. 71:6035-6044.
38. Meissner, A., V. Wild, R. Simm, M. Rohde, C. Erck, F. Bredenbruch, M. Morr, U. Romling, and S. Haussler. 2007. Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate. Environ. Microbiol. 9:2475-2485.
39. Michel-Briand, Y., and C. Baysse. 2002. The pyocins of Pseudomonas aeruginosa. Biochimie 84:499-510.
40. Mikkelsen, H., G. Ball, C. Giraud, and A. Filloux. 2009. Expression of Pseudomonas aeruginosa CupD fimbrial genes is antagonistically controlled by RcsB and the EAL-containing PvrR response regulators. PLoS One 4:e6018.
41. Miyata, S., M. Casey, D. W. Frank, F. M. Ausubel, and E. Drenkard. 2003. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect. Immun. 71:2404-2413.
42. Morton, D. B., and P. H. Griffiths. 1985. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet. Rec. 116:431-436.
43. Murphy, T. F., A. L. Brauer, K. Eschberger, P. Lobbins, L. Grove, X. Cai, and S. Sethi. 2008. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177:853-860.
44. Nicastro, G. G., and R. L. Baldini. 2007. Functional characterization of Pseudomonas aeruginosa virulence-related genes located in a pathogenicity island, abstr. F-20. Abstr. XXXVI Annu. Meet. Braz. Soc. Biochem. Mol. Biol. (SBBq)-10th IUBMB Conf., Salvador da Bahia, Brazil, 2007. http://sbbq.iq.usp.br/ arquivos/2007/cdlivro/resumos/R8586.pdf.
45. O'Toole, G. A., and R. Kolter. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461.
46. Qiu, X., A. U. Gurkar, and S. Lory. 2006. Interstrain transfer of the large pathogenicity island (PAPI-1) of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 103:19830-19835.
47. Rajakumar, K., C. Sasakawa, and B. Adler. 1997. Use of a novel approach, termed island probing, identifies the Shigella flexneri she pathogenicity island which encodes a homolog of the immunoglobulin A protease-like family of proteins. Infect. Immun. 65:4606-4614.
48. Rashid, M. H., and A. Kornberg. 2000. Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 97:4885-4890.
49. Rocchetta, H. L., L. L. Burrows, and J. S. Lam. 1999. Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 63:523-553.
50. Ryall, B., J. C. Davies, R. Wilson, A. Shoemark, and H. D. Williams. 2008. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients. Eur. Respir. J. 32:740-747.
51. Sadikot, R. T., T. S. Blackwell, J. W. Christman, and A. S. Prince. 2005. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171:1209-1223.
52. Schulert, G. S., H. Feltman, S. D. Rabin, C. G. Martin, S. E. Battle, J. Rello, and A. R. Hauser. 2003. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J. Infect. Dis. 188:1695-1706.
53. Schweizer, H. P. 1992. Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker. Mol. Microbiol. 6:1195-1204.
54. Shaver, C. M., and A. R. Hauser. 2004. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect. Immun. 72:6969-6977.
55. Simon, R., U. Priefer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Nat. Biotechnol. 1:784-791.
56. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406: 959-964.
57. Vogel, H. J., and D. M. Bonner. 1956. Acetylornithinase of Escherichia coli: partial purification and some properties. J. Biol. Chem. 218:97-106.
58. Walker, K. A., and V. L. Miller. 2009. Synchronous gene expression of the Yersinia enterocolitica Ysa type III secretion system and its effectors. J. Bacteriol. 191:1816-1826.
59. Wareham, D. W., and M. A. Curtis. 2007. A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates. Int. J. Med. Microbiol. 297:227-234.
60. West, S. E., H. P. Schweizer, C. Dall, A. K. Sample, and L. J. Runyen-Janecky. 1994. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148:81-86.
61. Wiehlmann, L., G. Wagner, N. Cramer, B. Siebert, P. Gudowius, G. Morales, T. Kohler, C. van Delden, C. Weinel, P. Slickers, and B. Tummler. 2007. Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 104:8101-8106.
62. Wolfgang, M. C., B. R. Kulasekara, X. Liang, D. Boyd, K. Wu, Q. Yang, C. G. Miyada, and S. Lory. 2003. Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 100:8484-8489.
63. Wurdemann, D., and B. Tummler. 2007. In silico comparison of pKLC102-like genomic islands of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 275:244-249.
64. Zhang, J., H. Li, J. Wang, Z. Dong, S. Mian, and F. S. Yu. 2004. Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 45: 2569-2576.
65. Zhang, Y., X. Li, A. Carpinteiro, and E. Gulbins. 2008. Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis. J. Immunol. 181:4247-4254.